Craig Porter
Concepts (328)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 32 | 2024 | 164 | 8.720 |
Why?
| | Muscle, Skeletal | 33 | 2026 | 815 | 4.390 |
Why?
| | Adipose Tissue, Brown | 15 | 2025 | 45 | 3.810 |
Why?
| | Mitochondria | 17 | 2025 | 446 | 3.520 |
Why?
| | Mitochondria, Muscle | 10 | 2026 | 43 | 3.400 |
Why?
| | Energy Metabolism | 17 | 2025 | 324 | 3.400 |
Why?
| | Thermogenesis | 9 | 2025 | 31 | 2.660 |
Why?
| | Adipose Tissue, White | 9 | 2022 | 35 | 2.440 |
Why?
| | Oxygen Consumption | 7 | 2025 | 201 | 1.710 |
Why?
| | Muscle Proteins | 13 | 2021 | 350 | 1.270 |
Why?
| | Glucose | 3 | 2023 | 361 | 1.150 |
Why?
| | Specimen Handling | 2 | 2026 | 63 | 1.130 |
Why?
| | Housing, Animal | 2 | 2025 | 18 | 1.100 |
Why?
| | Temperature | 2 | 2025 | 165 | 1.030 |
Why?
| | Blood Platelets | 2 | 2025 | 247 | 0.970 |
Why?
| | Exercise Therapy | 6 | 2021 | 105 | 0.960 |
Why?
| | Cachexia | 4 | 2019 | 28 | 0.950 |
Why?
| | Resistance Training | 7 | 2021 | 106 | 0.880 |
Why?
| | Cell Respiration | 7 | 2025 | 49 | 0.870 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2019 | 64 | 0.840 |
Why?
| | Male | 48 | 2026 | 27435 | 0.830 |
Why?
| | Physical Conditioning, Animal | 2 | 2023 | 67 | 0.820 |
Why?
| | Proteomics | 2 | 2023 | 336 | 0.800 |
Why?
| | Insulin Resistance | 6 | 2025 | 282 | 0.790 |
Why?
| | Animals | 24 | 2025 | 13526 | 0.780 |
Why?
| | Adipocytes | 2 | 2021 | 131 | 0.770 |
Why?
| | Humans | 64 | 2026 | 53230 | 0.730 |
Why?
| | Lipid Metabolism | 5 | 2019 | 189 | 0.730 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 84 | 0.720 |
Why?
| | Muscular Atrophy | 3 | 2021 | 73 | 0.700 |
Why?
| | Carnitine | 3 | 2019 | 67 | 0.680 |
Why?
| | Mice, Inbred BALB C | 6 | 2020 | 310 | 0.650 |
Why?
| | Quadriceps Muscle | 4 | 2021 | 47 | 0.640 |
Why?
| | Oxidative Phosphorylation | 3 | 2025 | 48 | 0.610 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 321 | 0.600 |
Why?
| | Mitochondrial Proteins | 6 | 2017 | 90 | 0.580 |
Why?
| | Sepsis | 2 | 2019 | 240 | 0.580 |
Why?
| | Mitochondria, Liver | 2 | 2018 | 69 | 0.570 |
Why?
| | Musculoskeletal Diseases | 1 | 2018 | 51 | 0.560 |
Why?
| | Stress, Physiological | 2 | 2016 | 184 | 0.560 |
Why?
| | Mice | 13 | 2025 | 5982 | 0.560 |
Why?
| | Down-Regulation | 2 | 2017 | 344 | 0.540 |
Why?
| | Methylhydrazines | 1 | 2017 | 1 | 0.540 |
Why?
| | Mitochondrial Diseases | 2 | 2015 | 45 | 0.530 |
Why?
| | Sex Characteristics | 1 | 2018 | 204 | 0.510 |
Why?
| | Adipose Tissue | 3 | 2025 | 210 | 0.510 |
Why?
| | Oxidative Stress | 3 | 2018 | 819 | 0.500 |
Why?
| | Amino Acids | 3 | 2020 | 382 | 0.500 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 1925 | 0.500 |
Why?
| | Female | 32 | 2026 | 28782 | 0.490 |
Why?
| | Electron Transport Complex II | 1 | 2015 | 7 | 0.460 |
Why?
| | Electron Transport Complex I | 1 | 2015 | 21 | 0.460 |
Why?
| | Adult | 18 | 2026 | 14534 | 0.450 |
Why?
| | Ion Channels | 4 | 2015 | 70 | 0.420 |
Why?
| | Liver | 6 | 2023 | 1150 | 0.410 |
Why?
| | Muscle Strength | 7 | 2021 | 132 | 0.400 |
Why?
| | Quality of Life | 1 | 2018 | 902 | 0.380 |
Why?
| | Glycogen | 2 | 2026 | 45 | 0.370 |
Why?
| | Young Adult | 11 | 2021 | 4511 | 0.360 |
Why?
| | Fungal Proteins | 3 | 2020 | 110 | 0.340 |
Why?
| | Health Status | 1 | 2013 | 306 | 0.340 |
Why?
| | Recovery of Function | 3 | 2021 | 203 | 0.340 |
Why?
| | Aging | 2 | 2017 | 714 | 0.340 |
Why?
| | Diet, High-Fat | 4 | 2021 | 243 | 0.340 |
Why?
| | Blood Glucose | 4 | 2017 | 490 | 0.320 |
Why?
| | Fibroblast Growth Factors | 2 | 2021 | 52 | 0.310 |
Why?
| | Metabolic Diseases | 2 | 2025 | 47 | 0.310 |
Why?
| | Muscular Diseases | 2 | 2020 | 64 | 0.310 |
Why?
| | Inflammation | 3 | 2024 | 652 | 0.310 |
Why?
| | Citrate (si)-Synthase | 3 | 2019 | 11 | 0.300 |
Why?
| | Obesity | 5 | 2025 | 1204 | 0.290 |
Why?
| | RNA, Messenger | 3 | 2017 | 1133 | 0.290 |
Why?
| | Cold Temperature | 4 | 2017 | 54 | 0.280 |
Why?
| | Child | 15 | 2022 | 7379 | 0.280 |
Why?
| | Basal Metabolism | 3 | 2018 | 32 | 0.280 |
Why?
| | Subcutaneous Fat | 2 | 2019 | 21 | 0.270 |
Why?
| | Middle Aged | 11 | 2026 | 13419 | 0.260 |
Why?
| | Case-Control Studies | 5 | 2017 | 1212 | 0.250 |
Why?
| | Child, Preschool | 7 | 2018 | 4162 | 0.250 |
Why?
| | Pregnancy in Diabetics | 2 | 2024 | 24 | 0.240 |
Why?
| | Muscle Weakness | 1 | 2026 | 46 | 0.240 |
Why?
| | RNA Stability | 1 | 2026 | 29 | 0.240 |
Why?
| | Buffers | 1 | 2025 | 12 | 0.240 |
Why?
| | Trachea | 1 | 2025 | 55 | 0.230 |
Why?
| | Adenosine Triphosphate | 1 | 2026 | 211 | 0.220 |
Why?
| | Adolescent | 10 | 2018 | 6907 | 0.220 |
Why?
| | Rats | 2 | 2023 | 3162 | 0.220 |
Why?
| | RNA | 1 | 2026 | 173 | 0.220 |
Why?
| | Lipids | 2 | 2023 | 163 | 0.220 |
Why?
| | Exercise | 5 | 2021 | 561 | 0.220 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2024 | 42 | 0.220 |
Why?
| | Time Factors | 5 | 2026 | 2991 | 0.220 |
Why?
| | Milk, Human | 1 | 2026 | 122 | 0.210 |
Why?
| | Receptors, Purinergic | 1 | 2024 | 13 | 0.210 |
Why?
| | Beverages | 2 | 2021 | 58 | 0.210 |
Why?
| | Body Composition | 5 | 2021 | 355 | 0.210 |
Why?
| | Critical Illness | 1 | 2026 | 316 | 0.200 |
Why?
| | Limb Salvage | 1 | 2023 | 43 | 0.200 |
Why?
| | Protein Biosynthesis | 3 | 2021 | 268 | 0.190 |
Why?
| | Weight Loss | 1 | 2025 | 257 | 0.190 |
Why?
| | Regeneration | 2 | 2020 | 83 | 0.190 |
Why?
| | Signal Transduction | 4 | 2024 | 1748 | 0.180 |
Why?
| | Ischemia | 1 | 2023 | 158 | 0.180 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2022 | 34 | 0.180 |
Why?
| | Trauma Severity Indices | 2 | 2019 | 51 | 0.180 |
Why?
| | Proteolysis | 2 | 2019 | 105 | 0.180 |
Why?
| | Diabetes, Gestational | 1 | 2022 | 52 | 0.180 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 44 | 0.170 |
Why?
| | Body Mass Index | 4 | 2018 | 717 | 0.170 |
Why?
| | Catecholamines | 1 | 2021 | 44 | 0.170 |
Why?
| | Bed Rest | 1 | 2021 | 36 | 0.170 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 205 | 0.170 |
Why?
| | Oxandrolone | 2 | 2018 | 10 | 0.170 |
Why?
| | Apoptosis | 2 | 2016 | 1139 | 0.160 |
Why?
| | Overnutrition | 1 | 2020 | 11 | 0.160 |
Why?
| | Adiposity | 3 | 2019 | 147 | 0.160 |
Why?
| | Hepatocytes | 2 | 2019 | 188 | 0.160 |
Why?
| | Propranolol | 2 | 2018 | 77 | 0.160 |
Why?
| | Myofibrils | 2 | 2020 | 20 | 0.160 |
Why?
| | Milk Proteins | 1 | 2020 | 77 | 0.160 |
Why?
| | Phenylalanine | 1 | 2020 | 136 | 0.160 |
Why?
| | Prospective Studies | 4 | 2018 | 2411 | 0.160 |
Why?
| | Lung | 3 | 2025 | 481 | 0.150 |
Why?
| | Capillaries | 1 | 2019 | 53 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 122 | 0.150 |
Why?
| | Aged | 8 | 2026 | 10429 | 0.150 |
Why?
| | Gonads | 1 | 2019 | 6 | 0.150 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2019 | 30 | 0.150 |
Why?
| | Metformin | 2 | 2017 | 84 | 0.150 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 25 | 0.150 |
Why?
| | Up-Regulation | 2 | 2017 | 456 | 0.150 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2021 | 108 | 0.150 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 109 | 0.140 |
Why?
| | Infant, Newborn | 3 | 2024 | 2913 | 0.140 |
Why?
| | Sarcopenia | 1 | 2019 | 100 | 0.140 |
Why?
| | Electron Transport | 1 | 2018 | 24 | 0.140 |
Why?
| | Weight Gain | 1 | 2019 | 245 | 0.140 |
Why?
| | Hep G2 Cells | 1 | 2018 | 38 | 0.140 |
Why?
| | Superoxides | 1 | 2018 | 46 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2017 | 31 | 0.140 |
Why?
| | National Institute of General Medical Sciences (U.S.) | 1 | 2017 | 1 | 0.140 |
Why?
| | Blotting, Western | 2 | 2016 | 587 | 0.140 |
Why?
| | Adenomatous Polyps | 1 | 2017 | 8 | 0.140 |
Why?
| | Cystathionine beta-Synthase | 1 | 2017 | 20 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2017 | 39 | 0.130 |
Why?
| | Chagas Disease | 1 | 2017 | 4 | 0.130 |
Why?
| | Appetite Regulation | 1 | 2017 | 13 | 0.130 |
Why?
| | Neuropeptides | 1 | 2017 | 36 | 0.130 |
Why?
| | Burns, Electric | 1 | 2017 | 2 | 0.130 |
Why?
| | Triglycerides | 1 | 2018 | 171 | 0.130 |
Why?
| | Multiple Organ Failure | 1 | 2017 | 51 | 0.130 |
Why?
| | Research Support as Topic | 1 | 2017 | 44 | 0.130 |
Why?
| | Adipocytes, Brown | 1 | 2017 | 9 | 0.130 |
Why?
| | Rats, Zucker | 1 | 2017 | 73 | 0.130 |
Why?
| | Myocardium | 2 | 2017 | 471 | 0.130 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 44 | 0.130 |
Why?
| | Physical Endurance | 1 | 2017 | 35 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2017 | 47 | 0.130 |
Why?
| | Colon | 1 | 2017 | 106 | 0.130 |
Why?
| | Infant | 4 | 2022 | 3805 | 0.130 |
Why?
| | Rats, Wistar | 1 | 2017 | 192 | 0.130 |
Why?
| | Fatty Acids | 1 | 2017 | 154 | 0.130 |
Why?
| | Chronic Disease | 2 | 2017 | 580 | 0.130 |
Why?
| | Palmitoylcarnitine | 1 | 2016 | 7 | 0.130 |
Why?
| | Blood Cells | 1 | 2016 | 37 | 0.120 |
Why?
| | Mice, Knockout | 4 | 2021 | 910 | 0.120 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 110 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 107 | 0.120 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 229 | 0.120 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2016 | 25 | 0.120 |
Why?
| | Motor Activity | 1 | 2017 | 227 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2017 | 120 | 0.120 |
Why?
| | Trauma Centers | 1 | 2017 | 210 | 0.120 |
Why?
| | Neck | 1 | 2016 | 97 | 0.120 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2015 | 10 | 0.120 |
Why?
| | Physical Education and Training | 1 | 2015 | 23 | 0.120 |
Why?
| | Proton Ionophores | 1 | 2015 | 3 | 0.120 |
Why?
| | Uncoupling Agents | 1 | 2015 | 5 | 0.120 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2015 | 5 | 0.120 |
Why?
| | Oligomycins | 1 | 2015 | 8 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 421 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2018 | 1049 | 0.110 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 116 | 0.110 |
Why?
| | Acute Disease | 1 | 2015 | 393 | 0.110 |
Why?
| | Cardiovascular System | 1 | 2015 | 55 | 0.110 |
Why?
| | Androgens | 1 | 2014 | 70 | 0.110 |
Why?
| | Anabolic Agents | 1 | 2014 | 41 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 1544 | 0.110 |
Why?
| | Insulin | 4 | 2019 | 493 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2023 | 5595 | 0.110 |
Why?
| | Biomedical Research | 1 | 2017 | 267 | 0.110 |
Why?
| | Risk Factors | 1 | 2023 | 4017 | 0.110 |
Why?
| | Overweight | 1 | 2016 | 232 | 0.100 |
Why?
| | Rest | 1 | 2014 | 60 | 0.100 |
Why?
| | Cohort Studies | 2 | 2015 | 1557 | 0.100 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 211 | 0.100 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 227 | 0.090 |
Why?
| | Pregnancy | 3 | 2025 | 2608 | 0.090 |
Why?
| | Biopsy | 1 | 2014 | 600 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 3 | 2017 | 182 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2025 | 1517 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2020 | 729 | 0.070 |
Why?
| | Professional Practice | 1 | 2008 | 18 | 0.070 |
Why?
| | Dietary Proteins | 2 | 2021 | 255 | 0.070 |
Why?
| | Body Weight | 2 | 2021 | 524 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2015 | 3494 | 0.070 |
Why?
| | Torque | 2 | 2018 | 16 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2019 | 561 | 0.060 |
Why?
| | Gene Expression | 2 | 2020 | 618 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2008 | 196 | 0.060 |
Why?
| | Mitochondria, Heart | 2 | 2017 | 39 | 0.060 |
Why?
| | Homeostasis | 2 | 2019 | 209 | 0.060 |
Why?
| | Kinetics | 2 | 2018 | 607 | 0.060 |
Why?
| | Pancreatic Elastase | 1 | 2025 | 18 | 0.060 |
Why?
| | Body Surface Area | 2 | 2016 | 26 | 0.060 |
Why?
| | Nutritional Support | 2 | 2015 | 31 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2024 | 6819 | 0.060 |
Why?
| | Exercise Test | 2 | 2017 | 137 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2016 | 333 | 0.060 |
Why?
| | Radiopharmaceuticals | 2 | 2017 | 198 | 0.060 |
Why?
| | Pediatrics | 1 | 2008 | 307 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2025 | 591 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 1003 | 0.050 |
Why?
| | Purinergic Antagonists | 1 | 2024 | 8 | 0.050 |
Why?
| | Intensive Care Units | 1 | 2026 | 243 | 0.050 |
Why?
| | Phenotype | 2 | 2019 | 803 | 0.050 |
Why?
| | Bariatric Surgery | 1 | 2025 | 44 | 0.050 |
Why?
| | Positron-Emission Tomography | 2 | 2017 | 298 | 0.050 |
Why?
| | Hemostasis | 1 | 2024 | 55 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2008 | 399 | 0.050 |
Why?
| | MicroRNAs | 1 | 2026 | 397 | 0.040 |
Why?
| | Thrombosis | 1 | 2024 | 250 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 94 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2021 | 114 | 0.040 |
Why?
| | Polyphenols | 1 | 2021 | 40 | 0.040 |
Why?
| | Immobilization | 1 | 2020 | 15 | 0.040 |
Why?
| | Leucine | 1 | 2021 | 114 | 0.040 |
Why?
| | Forearm | 1 | 2020 | 30 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2017 | 1180 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2019 | 22 | 0.040 |
Why?
| | Body Temperature Regulation | 1 | 2019 | 29 | 0.040 |
Why?
| | NF-kappa B | 1 | 2021 | 327 | 0.040 |
Why?
| | Hypertrophy | 1 | 2019 | 53 | 0.040 |
Why?
| | Mothers | 1 | 2022 | 269 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 372 | 0.040 |
Why?
| | Drinking | 1 | 2019 | 42 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 60 | 0.040 |
Why?
| | Athletic Injuries | 1 | 2020 | 193 | 0.040 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 140 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 235 | 0.030 |
Why?
| | Autophagy | 1 | 2019 | 199 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 13 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2017 | 13 | 0.030 |
Why?
| | Artifacts | 1 | 2018 | 55 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2017 | 29 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2017 | 43 | 0.030 |
Why?
| | HCT116 Cells | 1 | 2017 | 31 | 0.030 |
Why?
| | Antioxidant Response Elements | 1 | 2017 | 3 | 0.030 |
Why?
| | Gastric Inhibitory Polypeptide | 1 | 2017 | 3 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2017 | 8 | 0.030 |
Why?
| | Glucagon | 1 | 2017 | 24 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 374 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2017 | 78 | 0.030 |
Why?
| | Malaria | 1 | 2017 | 37 | 0.030 |
Why?
| | History, 21st Century | 1 | 2017 | 60 | 0.030 |
Why?
| | Ghrelin | 1 | 2017 | 31 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 163 | 0.030 |
Why?
| | History, 20th Century | 1 | 2017 | 97 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 232 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 670 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2019 | 195 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 370 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2017 | 122 | 0.030 |
Why?
| | Child, Hospitalized | 1 | 2017 | 33 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 465 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 243 | 0.030 |
Why?
| | ATP-Dependent Proteases | 1 | 2016 | 1 | 0.030 |
Why?
| | Endopeptidase Clp | 1 | 2016 | 3 | 0.030 |
Why?
| | PAX7 Transcription Factor | 1 | 2016 | 10 | 0.030 |
Why?
| | Palmitates | 1 | 2016 | 28 | 0.030 |
Why?
| | MyoD Protein | 1 | 2016 | 8 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Metabolism | 1 | 2016 | 25 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2016 | 26 | 0.030 |
Why?
| | Hyperinsulinism | 1 | 2016 | 30 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 314 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 166 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2016 | 25 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 279 | 0.030 |
Why?
| | Caspase 3 | 1 | 2016 | 92 | 0.030 |
Why?
| | Lipoproteins | 1 | 2016 | 41 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2016 | 63 | 0.030 |
Why?
| | Metabolomics | 1 | 2017 | 155 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 83 | 0.030 |
Why?
| | Leptin | 1 | 2017 | 151 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 109 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 600 | 0.030 |
Why?
| | Peroxidase | 1 | 2015 | 18 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 25 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 181 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 747 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 98 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 287 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2016 | 141 | 0.030 |
Why?
| | Antioxidants | 1 | 2017 | 264 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2019 | 1569 | 0.030 |
Why?
| | Cell Line | 1 | 2017 | 1016 | 0.030 |
Why?
| | Muscle Strength Dynamometer | 1 | 2014 | 12 | 0.030 |
Why?
| | Collagen | 1 | 2016 | 215 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 598 | 0.030 |
Why?
| | Survivors | 1 | 2015 | 120 | 0.030 |
Why?
| | Glucose Clamp Technique | 1 | 2014 | 15 | 0.030 |
Why?
| | Calorimetry, Indirect | 1 | 2014 | 25 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2014 | 49 | 0.030 |
Why?
| | Testosterone | 1 | 2014 | 142 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 226 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2014 | 160 | 0.030 |
Why?
| | DNA Damage | 1 | 2015 | 309 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 868 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2014 | 489 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2016 | 975 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 627 | 0.020 |
Why?
| | Macrophages | 1 | 2015 | 380 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2014 | 239 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1112 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 934 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2015 | 2318 | 0.020 |
Why?
| | United States | 1 | 2017 | 5409 | 0.020 |
Why?
|
|
Porter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|